News

FDA panel addresses risks of power morcellators in fibroid surgery

Publish date: July 11, 2014

 

References

Dr. Sobolewski disclosed being a consultant and speaker for Covidien, and is a consultant for and holds stock options in TransEnterix. (Neither company has morcellation products; Covidien manufactures specimen retrieval bags.) None of the panel members has relevant disclosures.

emechcatie@frontlinemedcom.com

Pages

Recommended Reading

Partially enclosed morcellation of a uterus during LSH using laparoscopic morcellation bag
MDedge ObGyn
How I am adapting my morcellation practice: Voices from across the country
MDedge ObGyn
Gynecologic Oncology Consult: Obesity and gynecologic surgery
MDedge ObGyn
I perform extracorporeal morcellation; Better vaginal surgery training needed; A patient's perspective
MDedge ObGyn
Midurethral sling study: At 5 years satisfaction remained high, though continence declined
MDedge ObGyn
Safety techniques regarding morcellation
MDedge ObGyn
Electromechanical power morcellation confined to a bag
MDedge ObGyn
Morcellation may be impractical
MDedge ObGyn
Guidelines call for minimum presurgical evaluation in uncomplicated SUI
MDedge ObGyn
Will open power morcellation of uterine tissue remain an option during hysterectomy and myomectomy?
MDedge ObGyn

Related Articles